AI assistant
Sending…
PUMA BIOTECHNOLOGY, INC. — Director's Dealing 2015
Aug 27, 2015
33488_dirs_2015-08-27_117d439d-df37-4acc-8a23-75e945ed1781.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: PUMA BIOTECHNOLOGY, INC. (PBYI)
CIK: 0001401667
Period of Report: 2015-08-26
Reporting Person: MOYES JAY M (Director)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2015-08-26 | Stock Option (Right to Buy) | $86.43 | A | 20000 | Acquired | 2025-08-25 | Common Stock (20000) | Direct |
Footnotes
F1: The vesting commencement date ("VCD") of the option is August 26, 2015. The option vests (i) with respect to one-third (1/3) of the shares underlying the option on the first anniversary of the VCD and (ii) with respect to 1/36th of the shares underlying the option, on each monthly anniversary of the VCD thereafter, subject to the Reporting Person's continued service through each vesting date as chair of the Audit Committee of the Board of Directors of the Issuer.
More from PUMA BIOTECHNOLOGY, INC.
Regulatory Filings
2026
May 7
Annual Report
2026
Apr 28
Major Shareholding Notification
2026
Mar 27
Annual Report
2026
Feb 26
Earnings Release
2026
Feb 26
Director's Dealing
2026
Feb 21
Director's Dealing
2026
Feb 21
Director's Dealing
2026
Feb 21
Director's Dealing
2026
Jan 8
Director's Dealing
2026
Jan 8